Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Sun Yat-sen University
Nektar Therapeutics
Sohag University
TG Therapeutics, Inc.
Fondazione Italiana Linfomi - ETS
Gilead Sciences
Roswell Park Cancer Institute
Celgene
Nanfang Hospital, Southern Medical University
Xinjiang Medical University
European Organisation for Research and Treatment of Cancer - EORTC
Lymphoma Study Association